Zepp Health (NYSE:ZEPP) Issues Quarterly Earnings Results

Zepp Health (NYSE:ZEPP) issued its quarterly earnings data on Tuesday. The company reported ($0.07) earnings per share for the quarter, FiscalAI reports. The business had revenue of $51.55 million during the quarter. Zepp Health had a negative return on equity of 15.15% and a negative net margin of 14.70%.

Zepp Health Trading Down 9.6%

NYSE:ZEPP opened at $3.99 on Thursday. The firm has a market cap of $58.50 million, a PE ratio of -1.58 and a beta of 1.78. The stock has a fifty day moving average price of $11.66 and a 200 day moving average price of $19.12. Zepp Health has a 12-month low of $2.25 and a 12-month high of $61.85. The company has a current ratio of 1.02, a quick ratio of 0.77 and a debt-to-equity ratio of 0.28.

Analyst Ratings Changes

Separately, Fundamental Research set a $56.28 price objective on Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $56.28.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Trivest Advisors Ltd purchased a new position in Zepp Health in the third quarter valued at $13,503,000. Keystone Investors PTE Ltd. purchased a new position in Zepp Health in the third quarter valued at $4,811,000. Millennium Management LLC boosted its holdings in Zepp Health by 49.1% in the fourth quarter. Millennium Management LLC now owns 366,826 shares of the company’s stock valued at $9,882,000 after purchasing an additional 120,750 shares during the period. FIL Ltd purchased a new position in Zepp Health in the fourth quarter valued at $16,858,000. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Zepp Health by 17.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 295,967 shares of the company’s stock valued at $7,974,000 after purchasing an additional 44,619 shares during the period. 52.61% of the stock is currently owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.